239 related articles for article (PubMed ID: 27030005)
1. [Heart rate and outcome in patients with acute and chronic heart failure].
Oliva F; Ammirati E; Campana C; Carubelli V; Cirò A; Di Tano G; Mortara A; Senni M; Morandi F; Metra M
G Ital Cardiol (Rome); 2016 Mar; 17(3 Suppl 1):3S-16. PubMed ID: 27030005
[TBL] [Abstract][Full Text] [Related]
2. Heart rate as a prognostic marker and therapeutic target in acute and chronic heart failure.
Oliva F; Sormani P; Contri R; Campana C; Carubelli V; Cirò A; Morandi F; Di Tano G; Mortara A; Senni M; Metra M; Ammirati E
Int J Cardiol; 2018 Feb; 253():97-104. PubMed ID: 29249470
[TBL] [Abstract][Full Text] [Related]
3. Prognostic Significance of Resting Heart Rate and Use of β-Blockers in Atrial Fibrillation and Sinus Rhythm in Patients With Heart Failure and Reduced Ejection Fraction: Findings From the Swedish Heart Failure Registry.
Li SJ; Sartipy U; Lund LH; Dahlström U; Adiels M; Petzold M; Fu M
Circ Heart Fail; 2015 Sep; 8(5):871-9. PubMed ID: 26243796
[TBL] [Abstract][Full Text] [Related]
4. Insufficient reduction in heart rate during hospitalization despite beta-blocker treatment in acute decompensated heart failure: insights from the ASCEND-HF trial.
Kitai T; Grodin JL; Mentz RJ; Hernandez AF; Butler J; Metra M; McMurray JJ; Armstrong PW; Starling RC; O'Connor CM; Swedberg K; Tang WH
Eur J Heart Fail; 2017 Feb; 19(2):241-249. PubMed ID: 27634557
[TBL] [Abstract][Full Text] [Related]
5. Advances in the management of heart failure: the role of ivabradine.
Müller-Werdan U; Stöckl G; Werdan K
Vasc Health Risk Manag; 2016; 12():453-470. PubMed ID: 27895488
[TBL] [Abstract][Full Text] [Related]
6. β-Blockers in Atrial Fibrillation Patients With or Without Heart Failure: Association With Mortality in a Nationwide Cohort Study.
Nielsen PB; Larsen TB; Gorst-Rasmussen A; Skjøth F; Lip GY
Circ Heart Fail; 2016 Feb; 9(2):e002597. PubMed ID: 26823497
[TBL] [Abstract][Full Text] [Related]
7. Beta-blockers and outcome in heart failure and atrial fibrillation: a meta-analysis.
Rienstra M; Damman K; Mulder BA; Van Gelder IC; McMurray JJ; Van Veldhuisen DJ
JACC Heart Fail; 2013 Feb; 1(1):21-8. PubMed ID: 24621795
[TBL] [Abstract][Full Text] [Related]
8. Extent of heart rate reduction during hospitalization using beta-blockers, not the achieved heart rate itself at discharge, predicts the clinical outcome in patients with acute heart failure syndromes.
Takahama H; Yokoyama H; Kada A; Sekiguchi K; Fujino M; Funada A; Amaki M; Hasegawa T; Asakura M; Kanzaki H; Anzai T; Kitakaze M
J Cardiol; 2013 Jan; 61(1):58-64. PubMed ID: 23165149
[TBL] [Abstract][Full Text] [Related]
9. Beta-blockers and ivabradine in chronic heart failure: from clinical trials to clinical practice.
Di Franco A; Sarullo FM; Salerno Y; Figliozzi S; Parrinello R; Di Pasquale P; Lanza GA
Am J Cardiovasc Drugs; 2014 Apr; 14(2):101-10. PubMed ID: 24327100
[TBL] [Abstract][Full Text] [Related]
10. The role of heart rate and ivabradine in acute heart failure.
Sciatti E; Vizzardi E; Bonadei I; Dallapellegrina L; Carubelli V
Monaldi Arch Chest Dis; 2019 Oct; 89(3):. PubMed ID: 31594282
[TBL] [Abstract][Full Text] [Related]
11. Heart rate control in patients with chronic atrial fibrillation and heart failure.
Silvet H; Hawkins LA; Jacobson AK
Congest Heart Fail; 2013; 19(1):25-8. PubMed ID: 22958623
[TBL] [Abstract][Full Text] [Related]
12. Role of ivabradine and heart rate lowering in chronic heart failure: guideline update.
Chow SL; Page RL; Depre C
Expert Rev Cardiovasc Ther; 2018 Jul; 16(7):515-526. PubMed ID: 29902387
[TBL] [Abstract][Full Text] [Related]
13. Discharge heart rate and β-blocker dose in patients hospitalized with heart failure: Findings from the OPTIMIZE-HF registry.
DeVore AD; Mi X; Mentz RJ; Fonarow GC; Van Dyke MK; Maya JF; Hardy NC; Hammill BG; Hernandez AF
Am Heart J; 2016 Mar; 173():172-8. PubMed ID: 26920611
[TBL] [Abstract][Full Text] [Related]
14. Heart rate as a target of treatment of chronic heart failure.
Hori M; Okamoto H
J Cardiol; 2012 Aug; 60(2):86-90. PubMed ID: 22920717
[TBL] [Abstract][Full Text] [Related]
15. Sinus rhythm versus atrial fibrillation in elderly patients with chronic heart failure--insight from the Cardiac Insufficiency Bisoprolol Study in Elderly.
Stankovic I; Neskovic AN; Putnikovic B; Apostolovic S; Lainscak M; Edelmann F; Doehner W; Gelbrich G; Inkrot S; Rau T; Herrmann-Lingen C; Anker SD; Düngen HD
Int J Cardiol; 2012 Nov; 161(3):160-5. PubMed ID: 22726401
[TBL] [Abstract][Full Text] [Related]
16. [The efficacy of ivabradine in chronic heart failure (review)].
Isakadze A; Makharadze T; Gvishiani M
Georgian Med News; 2015 Apr; (241):44-9. PubMed ID: 25953938
[TBL] [Abstract][Full Text] [Related]
17. Effect of early treatment with ivabradine combined with beta-blockers versus beta-blockers alone in patients hospitalised with heart failure and reduced left ventricular ejection fraction (ETHIC-AHF): A randomised study.
Hidalgo FJ; Anguita M; Castillo JC; Rodríguez S; Pardo L; Durán E; Sánchez JJ; Ferreiro C; Pan M; Mesa D; Delgado M; Ruiz M
Int J Cardiol; 2016 Aug; 217():7-11. PubMed ID: 27167103
[TBL] [Abstract][Full Text] [Related]
18. Is There a Role for Ivabradine in the Contemporary Management of Patients with Chronic Heart Failure in Academic and Community Heart Failure Clinics in Canada?
Roth S; Fernando C; Azeem S; Moe GW
Adv Ther; 2017 Jun; 34(6):1340-1348. PubMed ID: 28432646
[TBL] [Abstract][Full Text] [Related]
19. A low-dose β1-blocker effectively and safely slows the heart rate in patients with acute decompensated heart failure and rapid atrial fibrillation.
Kobayashi S; Murakami W; Myoren T; Tateishi H; Okuda S; Doi M; Nao T; Wada Y; Matsuzaki M; Yano M
Cardiology; 2014; 127(2):105-13. PubMed ID: 24296610
[TBL] [Abstract][Full Text] [Related]
20. Effects on outcomes of heart rate reduction by ivabradine in patients with congestive heart failure: is there an influence of beta-blocker dose?: findings from the SHIFT (Systolic Heart failure treatment with the I(f) inhibitor ivabradine Trial) study.
Swedberg K; Komajda M; Böhm M; Borer J; Robertson M; Tavazzi L; Ford I;
J Am Coll Cardiol; 2012 May; 59(22):1938-45. PubMed ID: 22617188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
